FDA Issues Eye Risk Warning for GLP-1 Medications
New labeling requirements highlight NAION risk, especially for sleep apnea patients taking popular weight loss drugs.
Medication Side Effects
When you buy through our links, we may earn a commission. As an Amazon Associate we earn from qualifying purchases. Learn more ›
New labeling requirements highlight NAION risk, especially for sleep apnea patients taking popular weight loss drugs.